 |
| 16-Aug-10 | Reiterated |
WBB Securities |
Strong Buy |
$5 → $6 |
|
| 26-Oct-07 | Downgrade |
Avondale Partners |
Mkt Outperform → Mkt Perform |
$19 |
|
|
|
| 16-May-13 10:25AM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 14-May-13 11:08PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ EDGAR Online |
| 13-May-13 05:10PM | Vision Sciences appoints Howard Zauberman as interim CEO theflyonthewall.com |
| 05:01PM | Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer GlobeNewswire |
| 30-Apr-13 10:19AM | Vision-Sciences' CEO Discusses F4Q2013 Results - Earnings Call Transcript at Seeking Alpha |
| 29-Apr-13 11:20PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 05:30PM | Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 GlobeNewswire |
| 07:07AM | Q4 2013 Vision Sciences Inc Earnings Release - After Market Close CCBN |
| 23-Apr-13 05:18PM | Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results GlobeNewswire |
| 18-Mar-13 04:05PM | Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System GlobeNewswire |
| 13-Mar-13 08:49AM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online |
| 12-Mar-13 04:38PM | Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors GlobeNewswire |
| 06-Mar-13 04:15PM | Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference GlobeNewswire |
| 07-Feb-13 02:36PM | Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference GlobeNewswire |
| 01-Feb-13 01:04PM | VISION SCIENCES INC /DE/ Financials EDGAR Online Financials +6.48% |
| 29-Jan-13 10:35AM | VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 28-Jan-13 05:16PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 05:15PM | Vision-Sciences Reports Net Sales of $4.0 Million for Third Quarter of Fiscal 2013 GlobeNewswire |
| 07:07AM | Q3 2013 Vision Sciences Inc Earnings Release - After Market Close CCBN |
| 21-Jan-13 07:30AM | Vision-Sciences Announces Release Date of Third Quarter of Fiscal 2013 Results GlobeNewswire |
| 16-Nov-12 01:04PM | VISION SCIENCES INC /DE/ Financials EDGAR Online Financials -6.31% |
| 08-Nov-12 08:49AM | Vision-Sciences to Present at Lazard Capital Markets 9th Annual Healthcare Conference GlobeNewswire |
| 05-Nov-12 04:31PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 04:30PM | Vision-Sciences Reports Net Sales of $3.7 Million for Second Quarter of Fiscal 2013 GlobeNewswire |
| 07:07AM | Q2 2013 Vision Sciences Inc Earnings Release - After Market Close CCBN |
| 29-Oct-12 10:32AM | InPlay: Vision-Sciences, Inc. reschedules release date of 2Q13 results due to expected severe weather conditions Briefing.com |
| 10:28AM | Vision-Sciences Reschedules Release Date of Second Quarter of Fiscal 2013 Results Due to Expected Severe Weather Conditions GlobeNewswire |
| 07:07AM | Q2 2013 Vision Sciences Inc Earnings Release - After Market Close CCBN |
| 22-Oct-12 07:30AM | Vision-Sciences Announces Release Date of Second Quarter of Fiscal 2013 Results GlobeNewswire |
| 12-Oct-12 10:00AM | Vision-Sciences, Inc. [VSCI] to Ring The NASDAQ Stock Market Closing Bell GlobeNewswire |
| 20-Sep-12 09:02AM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi EDGAR Online +7.50% |
| 31-Aug-12 12:04PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ EDGAR Online -7.09% |
| 21-Aug-12 01:04PM | VISION SCIENCES INC /DE/ Financials EDGAR Online Financials |
| 14-Aug-12 04:52PM | VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 01-Aug-12 07:33AM | InPlay: Vision-Sciences reports research study results demonstrate advantages of co's EndoSheath Technology for Bronchoscopy Briefing.com -7.55% |
| 07:30AM | Research Study Results Demonstrate Advantages of Vision-Sciences' EndoSheath(R) Technology for Bronchoscopy GlobeNewswire |
| 27-Jul-12 10:47AM | New Star Analyst Rankings for Vision-Sciences, Inc. StarMine +9.29% |
| 26-Jul-12 04:23PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fi EDGAR Online |
| 07:30AM | Vision-Sciences Reports Revenues of $3.4 Million for First Quarter 2013 GlobeNewswire |
| 07:07AM | Q1 2013 Vision Sciences Inc Earnings Release - Before Market Open CCBN |
| 23-Jul-12 08:56PM | Vision-Sciences Announces Release Date of First Quarter of Fiscal 2013 Results GlobeNewswire |
| 12-Jul-12 02:55PM | Stock Analysts' New Coverage for July 12th: AMZN, CMA, CUR, EMC, IBM, IMPV, JNPR, KIOR, LTM, MCO, VPHM, VSCI Thomson Reuters ONE +17.27% |
| 11-Jul-12 11:28AM | Equity Briefing: Stock Analysts' New Coverage for July 11th: AMZN, CMA, CUR, EMC, IMPV, IBM, JNPR, KIOR, LTM, MCO, VPHM, VSCI Thomson Reuters ONE +6.11% |
| 07:56AM | Vision Sciences initiated with a Buy at Lazard Capital at theflyonthewall.com |
| 01-Jun-12 01:04PM | VISION SCIENCES INC /DE/ Financials EDGAR Online Financials |
| 25-May-12 08:39AM | VISION SCIENCES INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online |
| 17-May-12 04:18PM | InPlay: Vision-Sciences, Inc. announces publication of clinical study utilizing its EndoSheath technology to diagnose esophageal disease: authors conclude that unsedated transnasal esophagoscopy is feasible Briefing.com |
| 04:15PM | Vision-Sciences Announces Peer-Reviewed Publication of Clinical Study Utilizing Its EndoSheath(R) Technology to Diagnose Esophageal Disease GlobeNewswire |
| 16-May-12 09:42AM | New Star Analyst Rankings for Vision-Sciences, Inc. StarMine -7.14% |
| 15-May-12 07:14AM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 07:07AM | Q4 2012 Vision Sciences Inc Earnings Release - Before Market Open CCBN |
| 07:00AM | Vision-Sciences Announces Record Revenue of $4.6 Million for Fourth Quarter and $16.7 Million for Full Year Fiscal 2012 GlobeNewswire |
| 08-May-12 04:15PM | Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2012 Results GlobeNewswire +7.46% |
| 27-Apr-12 04:55PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat EDGAR Online |
| 04:46PM | InPlay: Vision-Sciences announces purchase agreement for up to $15 mln with Lincoln Park Capital Fund, LLC Briefing.com |
| 04:44PM | Vision-Sciences Announces Purchase Agreement for up to $15 Million With Lincoln Park Capital Fund, LLC GlobeNewswire |
| 14-Mar-12 04:28PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 27-Feb-12 06:25PM | NYSE, NASDAQ and OTC Markets Listed Companies Join to Webcast Live, March 1st at RetailInvestorConferences.com PR Newswire |
| 11:47AM | Vision-Sciences to Present at the 32nd Cowen Health Care Conference Business Wire |
| 11:00AM | NYSE, NASDAQ and OTC Markets Listed Companies Join to Webcast Live, March 1st at RetailInvestorConferences.com PR Newswire |
| 04-Feb-12 01:04PM | VISION SCIENCES INC /DE/ Financials EDGAR Online Financials |
| 01-Feb-12 12:59PM | Vision-Sciences, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 2nd PR Newswire |
| 06:05AM | VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 31-Jan-12 05:27PM | InPlay: Vision-Sciences reports Q3 in-line Briefing.com -6.28% |
| 05:27PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 05:12PM | Vision-Sciences Reports Record Third Quarter Fiscal 2012 Net Sales of $4.3 Million Business Wire |
| 07:07AM | Q3 2012 Vision Sciences Inc Earnings Release - After Market Close CCBN |
| 30-Jan-12 03:56PM | CEOs Present and Take Questions Live, Online, February 2nd at RetailInvestorConferences.com PR Newswire +6.11% |
| 24-Jan-12 03:10PM | Vision-Sciences Announces Release Date of Third Quarter Fiscal 2012 Results Business Wire |
| 19-Jan-12 04:36PM | Intuitive Surgical Inc. Earnings: Profit Rises by Double-Figures for Fifth Consecutive Quarter Wall St. Cheat Sheet |
| 16-Jan-12 08:24PM | Intuitive Surgical Inc. Fourth Quarter Earnings Sneak Peek Wall St. Cheat Sheet |
| 08:22PM | Intuitive Surgical Inc. Fourth Quarter Earnings Sneak Peek Wall St. Cheat Sheet |
| 30-Dec-11 04:49PM | Vision Sciences files $25M mixed securities shelf theflyonthewall.com |
| 04:49PM | Vision Sciences files $25M mixed securities shelf at theflyonthewall.com |
| 19-Dec-11 04:23PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Shareholder Director Nominations, Other Events EDGAR Online |
| 05-Dec-11 07:57AM | [$$] Vision-Sciences Can Make Surgical Strikes at Barrons.com |
| 22-Nov-11 08:00AM | Cockrell Group to Represent Vision-Sciences' Investor Relations Business Wire |
| 11-Nov-11 01:04PM | VISION SCIENCES INC /DE/ Financials EDGAR Online Financials |
| 10-Nov-11 04:22PM | Vision-Sciences, Inc. to Present at Lazard Healthcare Conference on November 16, 2011 GlobeNewswire |
| 07-Nov-11 05:21PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 05:20PM | VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04:15PM | Vision-Sciences, Inc. Announces Net Sales Growth of 73% to $4.0 Million for the Second Quarter of Fiscal 2012 GlobeNewswire |
| 07:07AM | Q2 2012 Vision Sciences Inc Earnings Release - After Market Close CCBN |
| 02-Nov-11 04:29PM | Vision-Sciences, Inc. Schedules Second Quarter and First Half of Fiscal 2012 Conference Call for November 8, 2011 GlobeNewswire |
| 18-Oct-11 04:54PM | Intuitive Surgical, Inc. Earnings Cheat Sheet: Double-Digit Growth Again Wall St. Cheat Sheet |
| 04-Oct-11 04:27PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online |
| 19-Sep-11 09:30AM | Vision-Sciences' Pioneering Technology Featured on The Doctor Oz Show GlobeNewswire |
| 17-Sep-11 05:00AM | [video] Given's CEO Seeing Growth in Pill Cam Business at TheStreet.com |
| 16-Aug-11 01:04PM | VISION SCIENCES INC /DE/ Financials EDGAR Online Financials |
| 10-Aug-11 05:02PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State EDGAR Online |
| 04:46PM | VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 04:36PM | VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04:30PM | Vision-Sciences, Inc. Appoints Cynthia F. Ansari Chief Executive Officer GlobeNewswire |
| 04:30PM | Vision-Sciences, Inc. Announces $3.8 Million in Revenue for the First Quarter of Fiscal 2012 GlobeNewswire |
| 07:07AM | Q1 2012 Vision Sciences Inc Earnings Release - After Market Close CCBN |
| 08-Aug-11 10:43AM | Vision-Sciences, Inc. Schedules Fiscal 2012 Conference Call for August 11, 2011 GlobeNewswire -13.98% |
| 19-Jul-11 05:30PM | Intuitive Surgical, Inc. Earnings Cheat Sheet: Profits Grow Once Again Wall St. Cheat Sheet |
| 15-Jul-11 11:05AM | Exclusive Interview With The Executives: Vision-Sciences, Inc. - Warren Bielke, Lewis Pell And Katherine Wolf Wall Street Transcript +7.00% |
| 14-Jul-11 04:08PM | Intuitive Surgical, Inc. Second Quarter Earnings Preview Wall St. Cheat Sheet |
| 27-Jun-11 03:58PM | Wall Street's Best Hidden Stocks at Motley Fool |
|
|
| Vision-Sciences, Inc., together with its subsidiaries, designs, develops, manufactures, and markets products for endoscopy. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, and sells a line of endoscopy-based products, including flexible fiber and video endoscopes, as well as EndoSheath line of disposable sheaths to the urology; pulmonology; ear, nose, and throat (ENT); surgery; gastroenterology; and spine markets. This segment offers its endoscopy systems, EndoSheath technology, and related products to urologists, pulmonologists, gastroenterologists, bariatric surgeons, ENT doctors, and other airway management doctors in hospitals, medical clinics, and physicians' private offices. The Industrial segment designs, manufactures, and markets flexible borescopes under the Machida brand name. This segment offers various products, such as modulars, slim levers, knobs, battery operated portable flexible borescopes, industrial videoscopes, and portable video processors primarily to the aircraft engine manufacturing and aircraft engine maintenance industries. Vision-Sciences, Inc. provides its products through direct sales representatives in the United States; and through independent distributors in Europe, Asia, Australia, Canada, the Middle East, Africa, and central and South America. The company was founded in 1987 and is headquartered in Orangeburg, New York. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| PELL LEWIS C | Director | Mar 15 | Buy | 1.15 | 15,000 | 17,250 | 8,304,097 | Mar 19 06:05 AM | | PELL LEWIS C | Director | Mar 13 | Buy | 1.13 | 15,000 | 16,950 | 8,289,097 | Mar 19 06:05 AM | | PELL LEWIS C | Director | Mar 12 | Buy | 1.11 | 10,000 | 11,100 | 8,274,097 | Mar 13 01:49 PM | | PELL LEWIS C | Director | Mar 11 | Buy | 1.13 | 10,000 | 11,300 | 8,264,097 | Mar 13 01:49 PM | | PELL LEWIS C | Director | Mar 08 | Buy | 1.09 | 25,000 | 27,250 | 8,254,097 | Mar 13 01:49 PM | | PELL LEWIS C | Director | Mar 07 | Buy | 1.12 | 10,000 | 11,200 | 8,229,097 | Mar 08 05:26 PM | | PELL LEWIS C | Director | Mar 06 | Buy | 1.07 | 25,000 | 26,750 | 8,219,097 | Mar 08 05:26 PM | | PELL LEWIS C | Director | Mar 05 | Buy | 1.09 | 25,000 | 27,250 | 8,194,097 | Mar 08 05:26 PM | | PELL LEWIS C | Director | Mar 04 | Buy | 1.03 | 10,000 | 10,336 | 8,169,097 | Mar 05 11:36 AM | | PELL LEWIS C | Director | Mar 01 | Buy | 1.09 | 5,000 | 5,450 | 8,159,097 | Mar 05 11:36 AM | | PELL LEWIS C | Director | Feb 28 | Buy | 1.08 | 5,000 | 5,375 | 8,154,097 | Mar 05 11:36 AM | | PELL LEWIS C | Director | Feb 26 | Buy | 1.06 | 5,000 | 5,282 | 8,149,097 | Feb 27 11:11 AM | | PELL LEWIS C | Director | Feb 22 | Buy | 1.00 | 61,266 | 61,327 | 8,144,097 | Feb 27 11:11 AM | | PELL LEWIS C | Director | Feb 21 | Buy | 0.99 | 25,000 | 24,708 | 8,082,831 | Feb 22 09:36 AM | | PELL LEWIS C | Director | Feb 19 | Buy | 0.99 | 5,000 | 4,938 | 8,057,831 | Feb 20 03:36 PM | | PELL LEWIS C | Director | Feb 07 | Buy | 0.99 | 9,000 | 8,880 | 8,052,831 | Feb 08 12:44 PM | | PELL LEWIS C | Director | Feb 05 | Buy | 1.01 | 25,000 | 25,218 | 8,020,931 | Feb 06 11:40 AM | | PELL LEWIS C | Director | Feb 01 | Buy | 1.09 | 10,000 | 10,914 | 7,995,931 | Feb 05 02:26 PM | | PELL LEWIS C | Director | Feb 01 | Buy | 1.13 | 10,000 | 11,300 | 7,985,931 | Feb 04 05:13 PM | | PELL LEWIS C | Director | Jan 31 | Buy | 1.09 | 7,500 | 8,193 | 7,975,931 | Feb 04 05:13 PM | | PELL LEWIS C | Director | Dec 27 | Buy | 1.07 | 10,000 | 10,650 | 7,968,431 | Jan 02 12:02 PM | | PELL LEWIS C | Director | Dec 17 | Buy | 1.11 | 13,200 | 14,612 | 7,958,431 | Dec 20 02:27 PM | | PELL LEWIS C | Director | Dec 14 | Buy | 1.10 | 5,600 | 6,160 | 7,945,231 | Dec 20 02:27 PM | | PELL LEWIS C | Director | Dec 13 | Buy | 1.10 | 18,961 | 20,857 | 8,936,831 | Dec 18 05:31 PM | | PELL LEWIS C | Director | Dec 13 | Buy | 1.10 | 2,800 | 3,080 | 8,939,631 | Dec 20 02:27 PM | | PELL LEWIS C | Director | Dec 10 | Buy | 1.10 | 2,000 | 2,200 | 8,917,870 | Dec 13 12:22 PM | | PELL LEWIS C | Director | Dec 07 | Buy | 1.10 | 4,656 | 5,122 | 8,915,870 | Dec 13 12:22 PM | | PELL LEWIS C | Director | Dec 06 | Buy | 1.10 | 10,000 | 11,000 | 8,911,214 | Dec 07 03:44 PM | | PELL LEWIS C | Director | Dec 05 | Buy | 1.10 | 100 | 110 | 8,901,214 | Dec 07 03:44 PM | | PELL LEWIS C | Director | Dec 05 | Buy | 1.10 | 200 | 220 | 8,893,414 | Dec 06 04:24 PM | | PELL LEWIS C | Director | Dec 04 | Buy | 1.10 | 7,700 | 8,470 | 8,900,914 | Dec 07 03:44 PM | | PELL LEWIS C | Director | Dec 03 | Buy | 1.10 | 8,360 | 9,196 | 8,893,214 | Dec 05 03:29 PM | | PELL LEWIS C | Director | Nov 30 | Buy | 1.10 | 32,123 | 35,335 | 9,329,268 | Dec 03 02:41 PM | | PELL LEWIS C | Director | Nov 29 | Buy | 1.10 | 13,625 | 14,988 | 9,297,145 | Dec 03 02:41 PM | | PELL LEWIS C | Director | Nov 27 | Buy | 1.10 | 1,693 | 1,862 | 9,283,520 | Nov 28 10:11 AM | | PELL LEWIS C | Director | Nov 26 | Buy | 1.10 | 1,900 | 2,090 | 9,281,827 | Nov 28 10:11 AM | | PELL LEWIS C | Director | Nov 23 | Buy | 1.10 | 900 | 990 | 9,279,927 | Nov 26 01:59 PM | | PELL LEWIS C | Director | Nov 21 | Buy | 1.10 | 16,000 | 17,600 | 9,279,027 | Nov 26 01:59 PM | | PELL LEWIS C | Director | Nov 20 | Buy | 1.09 | 22,457 | 24,478 | 9,263,027 | Nov 26 01:59 PM | | PELL LEWIS C | Director | Nov 19 | Buy | 1.08 | 57,050 | 61,614 | 9,240,570 | Nov 19 05:33 PM | | PELL LEWIS C | Director | Nov 14 | Buy | 1.15 | 100,000 | 114,800 | 9,183,520 | Nov 15 02:26 PM | | PELL LEWIS C | Director | Nov 12 | Buy | 1.21 | 2,500 | 3,023 | 9,083,520 | Nov 14 01:50 PM | | PELL LEWIS C | Director | Nov 09 | Buy | 1.15 | 10,083 | 11,595 | 9,081,020 | Nov 14 01:50 PM | | PELL LEWIS C | Director | Nov 08 | Buy | 1.18 | 12,269 | 14,477 | 9,070,937 | Nov 14 01:50 PM | | PELL LEWIS C | Director | Sep 06 | Buy | 1.37 | 10,000 | 13,700 | 9,058,668 | Sep 07 05:23 PM | | PELL LEWIS C | Director | Jun 26 | Buy | 1.51 | 10,000 | 15,092 | 9,046,168 | Jun 27 02:55 PM | | PELL LEWIS C | Director | Jun 21 | Buy | 1.43 | 5,000 | 7,149 | 9,036,168 | Jun 26 05:28 PM | | PELL LEWIS C | Director | Jun 18 | Buy | 1.32 | 5,000 | 6,607 | 9,031,168 | Jun 19 03:45 PM | | PELL LEWIS C | Director | Jun 15 | Buy | 1.30 | 4,825 | 6,273 | 9,026,168 | Jun 18 02:15 PM | | PELL LEWIS C | Director | Jun 14 | Buy | 1.30 | 3,897 | 5,066 | 9,021,343 | Jun 15 04:30 PM | | PELL LEWIS C | Director | Jun 13 | Buy | 1.25 | 1,324 | 1,655 | 9,017,446 | Jun 15 04:30 PM | | PELL LEWIS C | Director | Jun 04 | Buy | 1.41 | 5,000 | 7,032 | 9,016,122 | Jun 05 03:31 PM | | PELL LEWIS C | Director | May 30 | Buy | 1.24 | 5,000 | 6,180 | 9,011,122 | Jun 01 03:40 PM | | PELL LEWIS C | Director | May 29 | Buy | 1.30 | 100,000 | 130,000 | 9,006,122 | May 30 03:29 PM |
|
|
|
|
|
|
